Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 880,400 | 1,187,900 | 1,674,700 | 994,800 | 1,817,200 |
| Marketable Securities | 1,026,900 | 22,000 | 21,500 | 1,037,400 | 4,632,100 |
| Receivables | 2,868,100 | 2,826,900 | 2,760,800 | 2,639,200 | 2,899,000 |
| Inventories | 846,900 | 894,600 | 922,500 | 948,400 | 904,500 |
| Other current assets | 34,000 | 7,300 | 0 | 0 | 0 |
| TOTAL | $6,475,400 | $5,740,200 | $6,103,700 | $6,393,300 | $11,376,700 |
| Non-Current Assets | |||||
| PPE Net | 1,787,000 | 1,756,600 | 1,761,400 | 1,769,500 | 1,785,400 |
| Investments And Advances | 1,970,600 | 302,800 | 297,900 | 267,100 | 267,900 |
| Intangibles | 89,608,700 | 97,583,800 | 99,615,500 | 102,626,000 | 104,511,200 |
| Other Non-Current Assets | 1,945,910 | 1,159,100 | 1,080,300 | 965,400 | 400,700 |
| TOTAL | $95,312,210 | $100,802,300 | $102,755,100 | $105,628,000 | $106,965,200 |
| Total Assets | $101,787,600 | $106,542,500 | $108,858,800 | $112,021,300 | $118,341,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 626,200 | 4,231,800 |
| Accounts payable and accrued liabilities | 4,787,200 | 4,695,600 | 4,683,800 | 5,072,300 | 5,541,400 |
| Other current liabilities | 868,300 | 1,351,600 | 1,348,500 | N/A | N/A |
| TOTAL | $5,727,900 | $6,231,900 | $6,125,300 | $5,816,000 | $9,848,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,929,400 | 22,231,800 | 24,002,000 | 25,936,400 | 25,843,500 |
| Other Non-Current Liabilities | 2,493,500 | 2,331,000 | 2,327,600 | 2,380,300 | 2,458,900 |
| TOTAL | $30,928,700 | $29,789,700 | $31,469,500 | $33,859,300 | $34,656,700 |
| Total Liabilities | $36,656,600 | $36,021,600 | $37,594,800 | $39,675,300 | $44,504,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 332,615 | 337,286 | 339,444 | 339,064 | 330,320 |
| Retained earnings | 7,258,900 | 11,800,600 | 12,082,900 | 12,799,500 | 12,957,200 |
| Other shareholders' equity | 1,362,100 | 1,517,300 | 1,613,400 | 2,059,600 | 1,936,700 |
| TOTAL | $65,131,000 | $70,520,900 | $71,264,000 | $72,346,000 | $73,837,100 |
| Total Liabilities And Equity | $101,787,600 | $106,542,500 | $108,858,800 | $112,021,300 | $118,341,900 |